| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/23/2009 | CN101538322A Polypeptide with inhibiting transcriptional activation activity of transcription factor, encoding gene thereof and application |
| 09/23/2009 | CN101538321A Plant ERF transcription factor and encoding gene and use of same |
| 09/23/2009 | CN101538320A Artificial zinc finger protein transcription factor capable of specifically regulating up HO-1 gene expression and application thereof |
| 09/23/2009 | CN101538318A Signal peptide, coding genes thereof and application |
| 09/23/2009 | CN101538307A Dehydroepiandrosterone hapten, artificial antigen and antibody as well as preparation method and application thereof |
| 09/23/2009 | CN101538266A Rogridone hapten, artificial antigen and antibody as well as preparation method and application thereof |
| 09/23/2009 | CN101537180A Recombinant production of mixtures of antibodies |
| 09/23/2009 | CN101537179A Long-acting animal rabies vaccine and preparing method thereof |
| 09/23/2009 | CN100543143C Process for enhanced production of pantothenate |
| 09/23/2009 | CN100543142C Method for altering the content of reserve substances in plants |
| 09/23/2009 | CN100543141C Method for producing gene engineering recombination 192 peptide human growth hormone |
| 09/23/2009 | CN100543140C Vector for anti-HPV vaccine and transformed microorganism by the vector |
| 09/23/2009 | CN100543139C HCV composite multi-epitope transgene plant oral vaccine |
| 09/23/2009 | CN100543138C Recombinant chicken-beta alexin protein Gal-9 preparation method |
| 09/23/2009 | CN100543137C Novel forms of interfering RNA molecules |
| 09/23/2009 | CN100543136C Seed specific USP promoters for expressing genes in plants |
| 09/23/2009 | CN100543135C Monoclonal antibody, gene encoding the same, medicinal composition and diagnostic reagent |
| 09/23/2009 | CN100542614C Virus envelope vector for gene transfer |
| 09/23/2009 | CN100542607C Anti-myelin associated glycoprotein (MAG) antibodies |
| 09/23/2009 | CN100542606C Vaccine composition comprising tumour antigen and adjuvant composition |
| 09/22/2009 | US7593819 Internal calibration standards for electrophoretic analyses |
| 09/22/2009 | US7592526 Plants and seeds of corn variety CV536449 |
| 09/22/2009 | US7592525 Plants and seeds of hybrid corn variety CH382226 |
| 09/22/2009 | US7592524 Maize variety X6H867 |
| 09/22/2009 | US7592523 Maize variety X6K239 |
| 09/22/2009 | US7592519 Soybean variety XB27D08 |
| 09/22/2009 | US7592517 Soybean variety D4463892 |
| 09/22/2009 | US7592516 Soybean variety D4328762 |
| 09/22/2009 | US7592515 Soybean cultivar 6910450 |
| 09/22/2009 | US7592514 Soybean cultivar S050225 |
| 09/22/2009 | US7592513 Soybean cultivar 6935331 |
| 09/22/2009 | US7592512 Soybean variety 4309194 |
| 09/22/2009 | US7592511 Soybean variety 0457028 |
| 09/22/2009 | US7592510 Lettuce cultivar 80-0601018-B |
| 09/22/2009 | US7592509 Isolated DNA sequences and polypeptides inducing multiple resistance of plants to phytopathogens and pests |
| 09/22/2009 | US7592508 High-efficiency Agrobacterium-mediated transformation of cotton using petiole explants |
| 09/22/2009 | US7592507 Generating stress resistant plant with enhanced biomass via plasmid transformation with vector comprising transcriptional regulatory protein (E2F) |
| 09/22/2009 | US7592506 Comprises an expression vector coding transactivator protein ZmMYB-IF35 for generating plants such as sorghum and maize which have modified flavonoids expression/concentrations |
| 09/22/2009 | US7592505 Used to inhibit arabinoxylan and/or hemicellulose production resulting in improved digestibility and/or ease of grain processing; harder pericarp when expressed in seed |
| 09/22/2009 | US7592504 Methods for determining specificity of RNA silencing and for genetic analysis of the silenced gene or protein |
| 09/22/2009 | US7592503 Producing transgenic animals for obtaining useful proteins; combining genome from activated donor cell with activated, enucleated oocyte to form nuclear transfer embryo for impregnation |
| 09/22/2009 | US7592502 Knock-in non-human animal producing human tissue factor |
| 09/22/2009 | US7592444 siRNA targeting myeloid cell leukemia sequence 1 |
| 09/22/2009 | US7592443 siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4) |
| 09/22/2009 | US7592441 miRNA for diagnosis, prognosis, and treatment of liver cancer |
| 09/22/2009 | US7592440 Identifying oligonucleotide subsequences associated with gene exprssion inhibition |
| 09/22/2009 | US7592439 Apolipoprotein receptor specific monoclonal antibody for use in the prevention and treatment of cell proliferative disorders |
| 09/22/2009 | US7592438 Human gene |
| 09/22/2009 | US7592437 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/22/2009 | US7592436 Gene encoding a protein having aurone synthesis activity |
| 09/22/2009 | US7592434 Pectate lyases, nucleic encoding them and methods for making and using them |
| 09/22/2009 | US7592433 cyclic peptides, signal peptide having animal or plant diagnostic/therapeutic properties; cyclization an encoded amino acid sequence within a cell or cell membrane; protecting crop plants, insecticidal proteins from pest |
| 09/22/2009 | US7592432 selectively splitting the polypeptide at a Cys-His site, by hydrolysis in presence of a palladium promotor dissolved in formic acid; purification with by-product inhibition |
| 09/22/2009 | US7592425 antibody binds a polypeptide; use in tissue targeted therapy; Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo; polypeptide-toxins |
| 09/22/2009 | US7592420 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 09/22/2009 | US7592325 Methods and compositions for the treatment of eye disorders with increased intraocular pressure |
| 09/22/2009 | US7592324 which include carbonic anhydrase II, IV, and XII, beta 1- and beta 2 adrenergic receptors, acetylcholinesterase, Na+/K+-ATPase, and Na K-2Cl cotransporter; RNA interference; intraocular hypertension, glaucoma |
| 09/22/2009 | US7592323 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/22/2009 | US7592322 RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof |
| 09/22/2009 | US7592321 Preventing/inhibiting metabolic disorders characterized by absence or reduced levels of alpha-L-iduronidase in newborn mammals by administering recombinant lentivirus comprising nucleic acid segment encoding alpha-L-iduronidase |
| 09/22/2009 | US7592319 Protein kinase (PK); for increasing the susceptibility of a cell to DNA-damaging agents via hybridization of nucleic acids encoding DNA dependent protein kinases, preventing gene expression; genetic engineering |
| 09/22/2009 | US7592318 88kDa tumorigenic growth factor and antagonists |
| 09/22/2009 | US7592317 Promoters operatively linked to genes encoding radiosensitizing or radioprotecting factors, administered to cells, tissues, or patients in conjunction with radiation exposure; tissue-targeted therapy |
| 09/22/2009 | US7592314 Use of VEGF and homologues to treat neuron disorders |
| 09/22/2009 | US7592310 Induction of antibiotic proteins and peptides by LAIT/sCD14-protein |
| 09/22/2009 | US7592309 Method of using a peptide having analgesic and antitumor activity from scorpion |
| 09/22/2009 | US7592188 Live cell biosensors |
| 09/22/2009 | US7592175 Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and cell cultures prepared using same |
| 09/22/2009 | US7592174 Isolation of mesenchymal stem cells |
| 09/22/2009 | US7592170 Selective precipitation of viruses using polyectrolytes |
| 09/22/2009 | US7592169 Methods and compositions for treatment and prevention of HSV-2 infections and conditions |
| 09/22/2009 | US7592168 Derived from Pseudomonas sp. SE83; has an improved reactivity and specific activity to CPC, which can be efficiently employed for directly preparing 7-ACA from CPC by a one-step enzymatic method |
| 09/22/2009 | US7592166 Enone reductase gene and microbial production of levodione |
| 09/22/2009 | US7592161 Expression vector for use as gene transfer tool in genetic engineering |
| 09/22/2009 | US7592160 Contacting saccharide having alpha-1,4 glucosidic linkage as linkage of non-reducing end and glucose polymerization degree of at least two, with an alpha-isomaltosyl-transferring enzyme and an alpha-isomaltosylglucosaccharide-forming enzyme derived from specific microorganism to produce isomaltose |
| 09/22/2009 | US7592159 Antibiotic alternatives |
| 09/22/2009 | US7592158 Polypeptides and polynucleotides, including vaccines against bacterial infections such as otitis media in infants and children, and pneumonia in elderlies |
| 09/22/2009 | US7592157 Using transgenic aspergillus as bioreactor for production of soybean trypsin inhibitor; treating inflammatory, respiratory, skin and arthritic disorders |
| 09/22/2009 | US7592156 Synthetic dog/human chimeric C-C chemokine receptor 2B |
| 09/22/2009 | US7592149 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 09/22/2009 | US7592145 Diagnosing prostate cancer in humans; obtaining tissue sample, monitoring marker gene expression, evaluating pattern for cancer; diagnostic and prognostic assays include methods involving the antibody-based detection of Pin1 and the amplification of Pin1 RNA |
| 09/22/2009 | US7592140 2′, 5′-oligoadenylate phosphodiesterase |
| 09/22/2009 | US7592137 Genetic testing kits and a method of bladder cancer |
| 09/22/2009 | US7592013 Administering a recombant food-grade bacterium expressing a trefoil peptide;delivering a TFF1 trefoil peptide in vivo expressed by a Lactococcus for lesion damage to the mucous membranes of the mouth caused by radiation; antinflammatory agents; gastrointestinal disorders |
| 09/22/2009 | US7592010 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 09/22/2009 | US7592007 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
| 09/22/2009 | CA2346927C Method for generating diversity |
| 09/22/2009 | CA2295957C Canine interleukin 18, canine interleukin 1.beta. converting enzyme, dna sequences encoding these, interleukin 18 production method and canine immune disease remedy |
| 09/22/2009 | CA2290354C Diagnostic system and method for determining the presence of a genotoxic compound in a sample |
| 09/22/2009 | CA2269752C Genomic ppo clones |
| 09/22/2009 | CA2253562C Genetic alterations associated with prostate cancer |
| 09/22/2009 | CA2241111C Process for the microbial production of amino acids by boosted activity of export carriers |
| 09/22/2009 | CA2239167C Aldolase catalytic antibody |
| 09/22/2009 | CA2200980C Mammalian receptors for modified low-density lipoprotein |
| 09/22/2009 | CA2191827C Protein which binds atp and nucleic acid and which possesses putative helicase and atpase properties |
| 09/22/2009 | CA2181417C Method and reagent for the specific determination of mrna |
| 09/22/2009 | CA2159551C Recombinant thermostable enzyme for converting maltose into trehalose |
| 09/22/2009 | CA2099125C Tapetum-specific promoters from brassicaceae spp |
| 09/20/2009 | CA2623243A1 Development of a novel cell-surface exposed luciferase as new multifunctional reporter for candida albicans |
| 09/19/2009 | CA2658520A1 Nucleic acid amplification in the presence of modified randomers |